praliciguat   Click here for help

GtoPdb Ligand ID: 9900

Synonyms: IW-1973 | IW1973
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Praliciguat (IW-1973) is a potent, orally available soluble guanylyl cyclase (sGC) stimulator [3]. sGC stimulators/activators have potential as heart failure therapeutics [1]. Praliciguat exhibits anti-hypertensive, reno-protective, anti-fibrotic effects and anti-inflammatory activities. Effects observed in renal fibrosis models suggests potential for the treatment of diabetic nephropathy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 101.89
Molecular weight 534.11
XLogP 5.42
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1cnc(nc1NCC(C(F)(F)F)(C(F)(F)F)O)c1nn(c(c1)c1nocc1)Cc1ccccc1F
Isomeric SMILES Fc1cnc(nc1NCC(C(F)(F)F)(C(F)(F)F)O)c1nn(c(c1)c1nocc1)Cc1ccccc1F
InChI InChI=1S/C21H14F8N6O2/c22-12-4-2-1-3-11(12)9-35-16(14-5-6-37-34-14)7-15(33-35)18-30-8-13(23)17(32-18)31-10-19(36,20(24,25)26)21(27,28)29/h1-8,36H,9-10H2,(H,30,31,32)
InChI Key CYSJNTQNMDWAJV-UHFFFAOYSA-N
Bioactivity Comments
Praliciguat (IW-1973)-induced prevention of inflammation and fibrosis in experimental non-alcoholic steatohepatitis was reported in early 2018 [2], suggesting another potential clinical use.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Guanylyl cyclase, α1β1 Hs Activator Activation 6.6 pEC50 - 3
pEC50 6.6 (EC50 2.67x10-7 M) [3]
Description: Concentration-dependent increase in the production of cGMP